 | Up a level |
Krenger, Pascal S; Josi, Romano; Sobczak, Jan; Velazquez, Thalia L C; Balke, Ina; Skinner, Murray A; Kramer, Matthias F; Scott, Callum J W; Hewings, Simon; Heath, Matthew D; Zeltins, Andris; Bachmann, Martin F (2024). Influence of antigen density and TLR ligands on preclinical efficacy of a VLP-based vaccine against peanut allergy. Allergy, 79(1), pp. 184-199. Wiley 10.1111/all.15897
Krenger, Pascal S; Sobczak, Jan; Paolucci, Marta; Kündig, Thomas M; Johansen, Pål; Vogel, Monique; Bachmann, Martin F (2023). BALB/c and C3H mice are both suitable as peanut allergy models. Clinical and experimental allergy, 53(12), pp. 1310-1313. Wiley 10.1111/cea.14398
Sobczak, Jan M; Krenger, Pascal S; Storni, Federico; Mohsen, Mona O; Balke, Ina; Reseviča, Gunta; Heath, Matthew D; Carreno Velazquez, Thalia L; Kramer, Matthias F; Scott, Callum J W; Skinner, Murray A; Zeltiņš, Andris; Kündig, Thomas M; Vogel, Monique; Bachmann, Martin F (2023). The next generation virus-like particle platform for the treatment of peanut allergy. Allergy, 78(7), pp. 1980-1996. Wiley-Blackwell 10.1111/all.15704
Rothen, Dominik A; Krenger, Pascal S; Nonic, Aleksandra; Balke, Ina; Vogt, Anne-Cathrine S; Chang, Xinyue; Manenti, Alessandro; Vedovi, Fabio; Resevica, Gunta; Walton, Senta M; Zeltins, Andris; Montomoli, Emanuele; Vogel, Monique; Bachmann, Martin F; Mohsen, Mona O (2022). Intranasal administration of a VLP-based vaccine induces neutralizing antibodies against SARS-CoV-2 and variants of concern. Allergy, 77(8), pp. 2446-2458. Wiley 10.1111/all.15311
Vogt, Anne-Cathrine S; Jörg, Lukas; Martina, Byron; Krenger, Pascal S; Chang, Xinyue; Zeltins, Andris; Vogel, Monique; Mohsen, Mona O; Bachmann, Martin F (2022). Virus-Like Particles Are Efficient Tools for Boosting mRNA-Induced Antibodies. Frontiers in immunology, 13, p. 864718. Frontiers Research Foundation 10.3389/fimmu.2022.864718
